Medifast provided earnings guidance for the first quarter of 2024. For the period, the company expects revenue to be in the range of $155 million to $175 million and diluted EPS to be in the range of $0.25 to $0.95.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.05 USD | -1.91% | -15.80% | -68.68% |
12:39pm | KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24 | MT |
Jun. 05 | DA Davidson Downgrades Medifast to Underperform From Neutral With $17.50 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.68% | 230M | |
+10.73% | 7.96B | |
+5.95% | 7.66B | |
-0.58% | 5.88B | |
-7.22% | 3.72B | |
-13.21% | 3.47B | |
-15.49% | 1.16B | |
-25.03% | 1.12B | |
+9.98% | 948M | |
-12.57% | 905M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast Provides Earnings Guidance for the First Quarter of 2024